Frequencies and characterization of HBV-specific cytotoxic T lymphocytes in self-limited and chronic hepatitis B viral infection in China

Xinxing Yang , Youhua Hao , Zhi Liu , Ling Chen , Honghui Ding , Xiping Zhao , Mengji Lu , Dongliang Yang

Current Medical Science ›› 2009, Vol. 29 ›› Issue (5) : 567 -574.

PDF
Current Medical Science ›› 2009, Vol. 29 ›› Issue (5) : 567 -574. DOI: 10.1007/s11596-009-0508-3
Article

Frequencies and characterization of HBV-specific cytotoxic T lymphocytes in self-limited and chronic hepatitis B viral infection in China

Author information +
History +
PDF

Abstract

Hepatitis B virus (HBV)-specific cytotoxic T lymphocytes (CTLs) are believed to play a major role in viral clearance and disease pathogenesis during HBV infection. To clarify the differences in host immune responses between self-limited and chronic HBV infections, we constructed three HLA-A*0201/HBV tetramers with immunodominant epitopes of core18–27, polymerase 575–583 and envelope 335–343, and analyzed the HBV-specific CTLs in peripheral blood mononuclear cells (PBMCs) from patients infected with HBV. The frequencies and expansion ability of HBV-specific CD8+ T cells in most self-limited HBV infected individuals were higher than those in chronic HBV-infected patients. HBV-specific CD8+ T cells could be induced by in vitro peptide stimulation from chronic patients with a low level of serum HBV-DNA but not from those with a high level of serum HBV-DNA. In chronic infection, no significant correlation was found either between the frequencies of HBV-specific CD8+ T cells and the viral load, or between the frequencies and the levels of alanine transaminase. Our results suggested that the frequencies of HBV-specific CTLs are not the main determinant of immune-mediated protection in chronic HBV infection and immunotherapeutic approaches should be aimed at not only boosting a HBV-specific CD8+ T response but also improving its function.

Keywords

hepatitis B virus / cytotoxic T lymphocyte / HLA-A*0201

Cite this article

Download citation ▾
Xinxing Yang, Youhua Hao, Zhi Liu, Ling Chen, Honghui Ding, Xiping Zhao, Mengji Lu, Dongliang Yang. Frequencies and characterization of HBV-specific cytotoxic T lymphocytes in self-limited and chronic hepatitis B viral infection in China. Current Medical Science, 2009, 29(5): 567-574 DOI:10.1007/s11596-009-0508-3

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

GuidottiL.G., ChisariF.V.. Immunobiology and pathogenesis of viral hepatitis. Annu Rev Pathol, 2006, 1: 23-61

[2]

TanA.T., KohS., GohV., et al.. Understanding the immunopathogenesis of chronic hepatitis B virus: an Asian prospective. J Gastroenterol Hepatol, 2008, 23(6): 833-843

[3]

MainiM.K., BoniC., LeeC.K., et al.. The role of virus-specific CD8+ cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med, 2000, 191(8): 1269-1280

[4]

BertolettiA., MainiM.K.. Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection?. Curr Opin Microbiol, 2000, 3(4): 387-392

[5]

ThimmeR., WielandS., SteigerC., et al.. CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol, 2003, 77(1): 68-76

[6]

WebsterG.J., ReignatS., BrownD., et al.. Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy. J Virol, 2004, 78(11): 5707-5719

[7]

GottoJ., WebsterG.J., BrownD., et al.. The impact of HBV-DNA fluctuations on virus-specific CD8+ T cells in HBeAg+ chronic hepatitis B patients treated with a steroid and lamivudine. J Viral Hepat, 2006, 13(6): 415-425

[8]

SingG.K., LadhamsA., ArnoldS., et al.. A longitudinal analysis of cytotoxic T lymphocyte precursor frequencies to the hepatitis B virus in chronically infected patients. J Viral Hepatol, 2001, 8(1): 19-29

[9]

BertolettiA., FerrariC.. Kinetics of the immune response during HBV and HCV infection. Hepatology, 2003, 38(1): 4-13

[10]

YangX.X., HaoY.H., DingH.H., et al.. Construction and primary application of three HBV HLA-A*0201-peptide tetramers. Mian Yi Xue Za Zhi (Chinese), 2008, 24(2): 146-149

[11]

GehringA.J., SunD., KennedyP.T., et al.. The level of viral antigen presented by hepatocytes influences CD8 T-cell function. J Virol, 2007, 81(6): 2940-2949

[12]

BoniC., FisicaroP., ValdattaC., et al.. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J Virol, 2007, 81(8): 4215-4225

[13]

BertolettiA., MainiM., WilliamsR.. Role of hepatitis B virus specific cytotoxic T cells in liver damage and viral control. Antiviral Res, 2003, 60(2): 61-66

[14]

WielandS.F., VegaR.G., MüllerR., et al.. Searching for interferon-induced genes that inhibit hepatitis B virus replication in transgenic mouse hepatocytes. J Virol, 2003, 77(2): 1227-1236

[15]

MurrayJ.M., WielandS.F., PurcellR.H., et al.. Dynamics of hepatitis B virus clearance in chimpanzees. Proc Natl Acad Sci, 2005, 102(49): 17 780-17 785

[16]

GehringA.J., SunD., KennedyP.T., et al.. The level of viral antigen presented by hepatocytes influences CD8 T-cell function. J Virol, 2007, 81(6): 2940-2949

AI Summary AI Mindmap
PDF

77

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/